focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 515.00
Bid: 515.00
Ask: 518.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.583%)
Open: 512.00
High: 518.00
Low: 512.00
Prev. Close: 515.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Feb 2011 07:00

RNS Number : 5974A
Creston PLC
03 February 2011
 

 

 

 

 

3 February 2011

 

Creston plc

Interim Management Statement 

 

Creston plc ("Creston" or the "Group") (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 October 2010 to 2 February 2011.

Trading update

For the nine months to 31 December 2010, the Group reported like-for-like revenue growth of over 6%.

Following its excellent revenue growth in the first half, the Communications Division continued to record good growth in the third quarter, winning a global eCRM project from new client, Sony Ericsson, alongside new briefs from existing clients, including Danone and Tropicana. In addition to continuing the new business growth, the Communications Division is achieving its objective of improving the profit conversion and margin on the reported revenue growth.

The Health Division increased its rate of growth from the first half by winning a number of new briefs from current clients. In the period, the new consumer health start-up won a joint pitch with the Communications Division for the UK launch of Asanor, a new consumer healthcare product for snoring.

In the Insight Division, the focus has been on driving new business development and new product initiatives following the appointment of a new senior management team at ICM. In the new calendar year, there has been a notable increase in commissions at ICM. It has commenced a significant programme of consumer research for the recent new client Sainsbury's; the Electoral Reform Society, another new client, has commissioned a project to test voters' attitudes ahead of the forthcoming alternative vote referendum; and BT, an established client, has commissioned an extensive qualitative research study across Asia and North America.

Corporate development in the period

The acquisition of Cooney/Waters and Alembic Health Communications was approved by shareholders on 15 December and the acquisition completed on 20 December 2010. This acquisition extends the Health Division's international service of clients and provides an excellent platform to pitch for global projects. Since acquisition, the integration programme of Cooney/Waters and Alembic Health Communications into the Group has progressed well, trading has been in line with expectations and in January there was a successful joint new business pitch with our UK healthcare PR agency, Red Door Communications. 

Outlook

The fourth quarter is traditionally Creston's strongest, and with positive momentum across the Group, management's expectations for the full year remain unchanged.

 For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

 

Barrie Brien, COO/CFO

Sarah Macleod, Communications Director

 

www.creston.com

 

 About Creston plc

Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across the Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAPAAEFKFEFF
Date   Source Headline
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results
17th Feb 20237:00 amRNSAppointment of Corporate Brokers
2nd Feb 20237:00 amRNSNotice of 2022 Results and Conference Call
25th Jan 20237:00 amRNSJanuary 2023 Renewals Trading Update
20th Jan 20232:00 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSNotice of 1 Jan 23 Renewals Trading Update Call
23rd Dec 20229:17 amRNSConduit Re welcomes AM Best affirming A- rating
20th Dec 20227:00 amRNSConduit Re welcomes AMBest affirmation of A rating
9th Nov 20227:00 amRNSThird Quarter 2022 Trading Update
3rd Nov 20227:00 amRNSNotice of Q3 2022 Trading Update
29th Sep 20225:23 pmRNSPurchase of Shares by Employee Benefit Trust
26th Sep 20221:36 pmRNSPurchase of Shares by Employee Benefit Trust
16th Sep 20225:40 pmRNSTransaction in Own Shares
7th Sep 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.